Difference between revisions of "Translocations et al. in Hematological Cancers"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[unchecked revision][unchecked revision]
Line 1: Line 1:
 
__TOC__
 
__TOC__
 +
 +
==Translocations==
  
 
{| class="wikitable"
 
{| class="wikitable"
 
|+Translocations
 
|+Translocations
 
|-
 
|-
|'''Anomaly'''
+
|'''ANOMALY'''
|'''Associated Disorders'''
+
|'''ASSOCIATED DISORDERS with FISH test'''
 +
|'''GENES'''
 +
|-
 +
|[[der(1)t(1;1)(p36;q21)]]
 +
|[[NHL]]
 +
|-
 +
|[[t(1;3)(p36;q21)]]
 +
|[[MDS]],[[ AML]]
 +
|[[PRDM16(MEL1)-RPN1]]
 +
|-
 +
|[[t(1;3;5)(p36;p21;q33) ]]
 +
|[[CEL]]
 +
|[[WDR48-PDGFRB]]
 +
|-
 +
|[[t(1;5)(q21;q33)]]
 +
|[[MPD]]
 +
|[[TPM3-PDGFRB ]]
 +
|-
 +
|[[t(1;5)(q22;q33)]]
 +
|[[MPD with eosinophilia]],[[ CEL]],[[ B-ALL]]
 +
|[[PDE4DIP-PDGFRB]]
 +
|-
 +
|[[der(1;7)(q10;p10)]]
 +
|[[MDS]],[[ AML]],[[ MPD]]
 +
|-
 +
|[[t(1;8)(p13;q24.1)]]
 +
|Missing
 +
| [[MYC(C-MYC)]]
 +
|-
 +
|[[t(1;14)(q21;q32)  A B C D]]
 +
|[[B-ALL]],[[ NHL]]
 +
|[[BCL9-IGH]],[[ FCGR2B-IGH]],[[ FCRL4-IGH]],[[ MUC1/IGH]]
 +
|-
 +
|[[t(1;19)(q23;p13.3) ]]
 +
|[[B-ALL]]
 +
|[[PBX1-TCF3(E2A)]]
 +
|-
 +
|[[der(1;22)(q10;p10)]]
 +
|-
 +
|[[t(2;5)(p23;q35)]]
 +
|[[ALCL]],[[ NHL]]
 +
|[[ALK-NPM1]]
 +
|-
 +
|[[t(2;8)(p12;q24.1)]]
 +
|[[BL]],[[ B-ALL]],[[ NHL ]]
 +
|[[MYC(C-MYC)]]
 +
|-
 +
|[[t(2;11)(p21;q23)]]
 +
|[[MDS]],[[ AML]],[[ B-ALL]]
 +
|[[MLL]]
 +
|-
 +
|[[t(2;14)(p15;q32)]]
 +
|[[CLL]],[[ NHL]],[[ B-ALL]],[[ T-ALL]],[[ AML]]
 +
|-
 +
|[[t(3;3)(q21;q26.2) ]]
 +
|[[MDS]],[[ AML]]
 +
|[[RPN1-MECOM(EVI1)]]
 
|-
 
|-
|Bread
+
|[[t(3;5)(p21-25;q32-35)]]
|Pie
+
|[[MPD]]
 +
|[[GOLGA4-PDGFRB ]]
 
|-
 
|-
|Butter
+
|[[t(3;21)(q26.2;q22)  A ]]
|Ice cream
+
|[[ t-AML]],[[ t-MDS]]
 +
|[[RPL22(EAP)-RUNX1(AML1)]]
 
|-
 
|-
|der(1)t(1;1)(p36;q21)
+
|[[t(4;11)(q21;q23)]]
|[[NHL]],MDS
+
|[[B-ALL]],[[ T-ALL]]
 +
|[[AFF1(AF4)-MLL]]
 +
|-
 +
|[[t(4;14)(p16.3;q32)]]
 +
|[[MM]]
 +
|[[ FGFR3-IGH]]
 +
|-
 +
|[[t(4;22)(q12;q11)]]
 +
|[[atypical MPD]]
 +
|[[ PDGFRA -BCR]]
 +
|-
 +
|[[t(4;5;5)(q23;q31;q33)]]
 +
|[[chronic basophilic leukemia]]
 +
|[[PRKG2-PDGFRB]]
 +
|-
 +
|[[t(5;7)(q33;q11.2)]]
 +
|[[CMML]]
 +
|[[HIP1-PDGFRB]]
 +
|-
 +
|[[t(5;10)(q33;q21)]]
 +
|[[atypical MPD]]
 +
|[[CCD6-PDGFRB]]
 +
|-
 +
|[[t(5;12)(q31;p13)]]
 +
|[[CEL]],[[ MPD]]
 +
|[[ETV6(TEL)-ACSL6 ]]
 +
|-
 +
|[[t(5;12)(q33;q24)]]
 +
|[[MPD with eosinophilia  ]]
 +
|[[GIT2-PDGFRB]]
 +
|-
 +
|[[t(5;12)(q33;p13)]]
 +
|[[CMML]],[[ MDS]],[[ MPD]]
 +
|[[ETV6(TEL)-PDGFRB]]
 +
|-
 +
|[[t(5;14)(q33;q24)]]
 +
|[[MPD]],[[ atypical MPD]]
 +
|[[NIN-PDGFRB]]
 +
|-
 +
|[[t(5;14)(q33;q32)]]
 +
|[[CCDC88C(KIAA1509)-PDGFRB]]
 +
|-
 +
|[[t(5;15)(q33;q22)]]
 +
|[[CMML atypical MPD]]
 +
|[[TP53BP1-PDGFRB]]
 +
|-
 +
|[[t(5;14)(q35;q32)]]
 +
|[[T-cell lymphoma]]
 +
|[[TLX3(HOX11L2)-BCL11B]]
 +
|-
 +
|[[t(5;16)(q33;q22)]]
 +
|[[AML]]
 +
|[[CBFB]]
 +
|-
 +
|[[der(5;17)(p10;q10)]]
 +
|[[MDS]],[[ AML]]
 +
|[[NPM1(NPM)-RARA]]
 +
|-
 +
|[[t(5;17)(q33;p11.2)]]
 +
|[[JMML ]]
 +
|[[SPECC1-PDGFRB]]
 +
|-
 +
|[[t(5;17)(q33;p13)]]
 +
|[[CMML]],[[ atypical MPD]]
 +
|[[RABEP1-PDGFRB ]]
 +
|-
 +
|[[der(6)t(1;6)(q21;p21.3)]]
 +
|[[PMF]]
 +
|-
 +
|[[t(6;9)(p23;q34) ]]
 +
|[[MDS]],[[ AML]]
 +
|[[DEK-NUP214 (CAN)]]
 +
|-
 +
|[[t(6;11)(q27;q23) ]]
 +
|[[AML]],[[ t-AML]],[[ T-ALL]]
 +
|[[MLLT4(AF6)-MLL]]
 +
|-
 +
|[[t(7;11)(p15;p15)]]
 +
|[[AML]]
 +
|[[NUP98-HOXA9]]
 +
|-
 +
|[[t(8;14)(q24.1;q32) ]]
 +
|[[BL]],[[ B-ALL]],[[ NHL]]
 +
|[[MYC(C-MYC)- IGH]]
 +
|-
 +
|[[t(8;16)(p11.2;p13.3)  A]]
 +
|[[AML M4]],[[ M5a]],[[ M5b]],[[ t-MDS]]
 +
|[[KAT6A(MYST3)-CREBBP(CBP)]]
 +
|-
 +
|[[t(8;21)(q22;q22) A ]]
 +
|[[AML M2 mostly]],[[ rarely M1]],[[ M4]]
 +
|[[RUNX1(AML)-RUNX1T1(ETO)]]
 +
|-
 +
|[[t(8;22)(q24.1;q11.2) ]]
 +
|[[BL]],[[ B-ALL]],[[ NHL]],[[ MM]]
 +
|[[MYC(C-MYC)-IGL(IGL)]]
 +
|-
 +
|[[add(9)(p24)]]
 +
|[[JAK2]]
 +
|-
 +
|[[t(9;11)(p22;q23)]]
 +
|[[AML mostly M5]],[[ M4]],[[ B-ALL]]
 +
|[[MLLT3(AF9)-MLL]]
 +
|-
 +
|[[t(9;14)(p13;q32)]]
 +
|[[MM]],[[ CLL]],[[ DLBCL]],[[ FL]],[[ MCL splenic MZL]]
 +
|[[PAX5-IGH]]
 +
|-
 +
|[[t(9;22)(q34;q11.2) A B ]]
 +
|[[CML]],[[ B-ALL]],[[  T-ALL]]
 +
|[[ABL1(ABL)-BCR]]
 +
|-
 +
|[[t(11;14)(q13;q32) A ]]
 +
|[[MCL]],[[ MM]]
 +
|[[CCND1(BCL1)- IGH]]
 +
|-
 +
|[[t(11;14)(q23;q32)]]
 +
|[[t-AML]]
 +
|[[MLL-KIAA0284]]
 +
|-
 +
|[[t(11;16)(q23;p13.3)]]
 +
|[[t-MDS]],[[ t-AML]]
 +
|[[MLL-CREBBP(CBP)]]
 +
|-
 +
|[[t(11;17)(q23;q21)]]
 +
|[[APL]]
 +
|[[ZBTB16(PLZF)-RARA]]
 +
|-
 +
|[[t(11;18)(q21;q21)]]
 +
|[[MALT]]
 +
|[[BIRC3(API2)-MALT1]]
 +
|-
 +
|[[t(11;19)(q23;p13.1) ]]
 +
|[[AML]]
 +
|[[MLL-ELL]]
 +
|-
 +
|[[t(11;19)(q23;p13.3) ]]
 +
|[[B-ALL]],[[ AML]],[[ T-ALL]]
 +
|[[MLL-MLLT1(ENL)]]
 +
|-
 +
|[[t(14;16)(q32;q23)]]
 +
|[[MM]]
 +
|[[IGH-MAF]]
 +
|-
 +
|[[t(14;18)(q32;q21) ]]
 +
|[[BL]],[[ DLBCL]],[[ FL]],[[ CLL]]
 +
|[[IGH-BCL2]]
 +
|-
 +
|[[t(14;19)(q32;q13.3)]]
 +
|[[CLL]],[[ DLBCL]],[[ MCL]],[[ MZL]],[[ SLVL]]
 +
|-
 +
|[[t(14;22)(q32;q11.2)]]
 +
|[[B-ALL]],[[ CLL]],[[ HCL]],[[ AML]],[[ NHL]],[[ DLBCL]]
 +
|[[IGH-IGL]]
 +
|-
 +
|[[t(15;17)(q24;q21)]]
 +
|[[APL]]
 +
|[[PML-RARA]]
 +
|-
 +
|[[t(16;16)(p13.1;q22) ]]
 +
|[[AML M4Eo]]
 +
|[[MYH11-CBFB]]
 +
|-
 +
|[[der(19)t(1;19)(q23;p13.3)]]
 +
|[[B-ALL]],[[ L3-like ALL]],[[ T-ALL]],[[ NHL]],[[ AML]]
 +
|[[PBX1-TCF3(E2A)]]
 +
|-
 +
|[[der(Y)t(Y;1)(q12;q12) ]]
 +
|[[MDS]]
  
 
|}
 
|}
  
==Myelodysplastic Syndromes (MDS)==
 
  
: [[+11 or trisomy 11 (solely) KMT2A]]
+
==Inversions==
: [[+13 or trisomy 13]]
 
: [[+14 or trisomy 14 (solely)]]
 
: [[+15 or trisomy 15 (as sole autosomal abnormality)]]
 
: [[+16 or trisomy 16 (solely)]]
 
: [[+18 or trisomy 18 in lymphoproliferative disorders]]
 
: [[+20 or trisomy 20 (solely)]]
 
: [[+21 or trisomy 21]]
 
: [[+6 or trisomy 6]]
 
: [[+7 or trisomy 7 (solely)]]
 
: [[+8 or trisomy 8]]
 
: [[+9 or trisomy 9]]
 
: [[-21 or monosomy 21 (solely)]]
 
: [[-7/del(7q) in adults]]
 
: [[-7/del(7q) in childhood]]
 
: [[11q23 rearrangements (KMT2A) in leukaemia]]
 
: [[12p abnormalities in myeloid malignancies]]
 
: [[1q translocations (unbalanced) in myeloid malignancies]]
 
: [[1q triplication in hematologic malignancies]]
 
: [[3q26 rearrangements (MECOM) in myeloid malignancies]]
 
: [[Atypical Chronic Myeloid Leukemia (aCML)]]
 
: [[Childhood myelodysplastic syndromes]]
 
: [[Classification of myelodysplasic syndromes]]
 
: [[Congenital leukaemias]]
 
: [[Infant leukaemias]]
 
: [[Isolated tetrasomy 8 in AML, MDS and MPD]]
 
: [[MLL amplification in leukemia]]
 
: [[Monosomal karyotype (MK) in myeloid malignancies]]
 
: [[Neonatal leukaemias]]
 
: [[Refractory anemia (RA)]]
 
: [[Refractory anemia with excess blasts (RAEB)]]
 
: [[Refractory anemia with ringed sideroblasts (RARS)]]
 
: [[Trisomy 19]]
 
: [[Trisomy 2]]
 
: [[Y loss in leukemia]]
 
: [[del (3q)]]
 
: [[del (13q)]]
 
: [[del(13q) in myeloid malignancies]]
 
: [[del(16)(q22) CBFB/MYH11]]
 
: [[del(17p) in myeloid malignancies]]
 
: [[del(20q) in myeloid malignancies]]
 
: [[del(21)(q21q22) USP16/RUNX1]]
 
: [[del(5q) in myeloid neoplasms]]
 
: [[del(9q) solely]]
 
: [[dic(17;20)(p11.2;q11.2)]]
 
: [[dic(1;15)(p11;p11)]]
 
: [[i(17q) solely in myeloid malignancies]]
 
: [[i(5)(p10) in acute myeloid leukemia]]
 
: [[ider(20q) in Myeloid Malignancies]]
 
: [[idic(X)(q13)]]
 
: [[ins(3;3)(q26;q21q26) PSMD2/MECOM]]
 
: [[inv(11)(p15q22) NUP98/DDX10]]
 
: [[inv(11)(q21q23) KMT2A/MAML2 in therapy related leukemias]]
 
: [[inv(12)(p13q15) ETV6/PTPRR]]
 
: [[inv(16)(p13q22) CBFB/MYH11]]
 
: [[inv(18)(p11q21)]]
 
: [[inv(3)(q21q26) PSMD2/MECOM]]
 
: [[inv(6)(p15q13)]]
 
: [[inv(6)(p25q13)]]
 
: [[t(10;12)(q24;p13) ETV6/GOT1]]
 
: [[t(10;16)(q22;p13) KAT6B/CREBBP]]
 
: [[t(11;11)(p15;q22) NUP98/DDX10]]
 
: [[t(11;14)(p15;q22) AP2A2/NID2]]
 
: [[t(11;16)(q23;p13.3) KMT2A/CREBBP]]
 
: [[t(11;17)(q23;q25) KMT2A/SEPT9]]
 
: [[t(11;20)(p15;q11) NUP98/TOP1]]
 
: [[t(11;21)(q13;q22) RUNX1/MACROD1]]
 
: [[t(12;12)(p13;q13) ETV6/BAZ2A]]
 
: [[t(12;12)(p13;q13) HMGA2/?]]
 
: [[t(12;13)(p12;q12-14) ETV6/CDX2]]
 
: [[t(12;13)(p13;q14) LIN00598/ETV6]]
 
: [[t(12;14)(q13;q31) HMGA2/?]]
 
: [[t(12;17)(p13;p13) ETV6/PER1]]
 
: [[t(12;18)(p13;q12) ETV6/SETBP1]]
 
: [[t(12;20)(q15;q11.2) HMGA2 truncated]]
 
: [[t(12;22)(p13;q12) MN1/ETV6]]
 
: [[t(14;21)(q22;q22) RUNX1/?]]
 
: [[t(15;21)(q22;q22) RUNX1/?]]
 
: [[t(16;16)(p13;q22) CBFB/MYH11]]
 
: [[t(16;21)(q24;q22) RUNX1/CBFA2T3]]
 
: [[t(1;11)(p32;q23) KMT2A/EPS15]]
 
: [[t(1;12)(p36;p13) ETV6/MDS2]]
 
: [[t(1;12)(q21;p13) ETV6/ARNT]]
 
: [[t(1;12)(q21;q24)]]
 
: [[t(1;16)(q11;q11)]]
 
: [[t(1;18)(q10;q10)]]
 
: [[t(1;19)(p13;p13.1)]]
 
: [[t(1;2)(p36;p21) PRDM16 and LINC00982/?]]
 
: [[t(1;21)(p36;q22) RUNX1/PRDM16]]
 
: [[t(1;3)(p36;p21)]]
 
: [[t(1;3)(p36;q21) PSMD2/PRDM16]]
 
: [[t(1;6)(p36;p21)]]
 
: [[t(1;7)(q10;p10)]]
 
: [[t(20;21)(q13.2;q22.12) ZFP64/RUNX1]]
 
: [[t(20;21)(q13;q22) RUNX1/?]]
 
: [[t(2;11)(p21;q23) KMT2A/?]]
 
: [[t(2;11)(q31;p15) NUP98/HOXD11]]
 
: [[t(2;11)(q31;p15) NUP98/HOXD13]]
 
: [[t(2;12)(q31;p13) ETV6/?]]
 
: [[t(2;3)(p15-23;q26-27) ?/MECOM]]
 
: [[t(2;3)(p15-23;q26-27) ?/MECOM]]
 
: [[t(2;4)(p23;q25-q35)]]
 
: [[t(3;11)(p25;p15) ANKRD28/NUP98]]
 
: [[t(3;11)(q12;p15) NUP98/LNP1]]
 
: [[t(3;12)(q26;p13) ETV6/EVI1]]
 
: [[t(3;12)(q26;p13) ETV6/MECOM]]
 
: [[t(3;16)(q21;q22)]]
 
: [[t(3;18)(q26;q11) ?/MECOM]]
 
: [[t(3;21)(q26;q22) RUNX1/MECOM]]
 
: [[t(3;3)(p24;q26) ?/MECOM]]
 
: [[t(3;3)(q21;q26) PSMD2/MECOM]]
 
: [[t(3;4)(p21;q34)]]
 
: [[t(3;5)(q21;q31)]]
 
: [[t(3;5)(q25;q34) NPM1/MLF1]]
 
: [[t(3;8)(q26;q24) PVT1/MECOM]]
 
: [[t(4;11)(p12;q23) KMT2A/FRYL]]
 
: [[t(4;5)(q31;q31)]]
 
: [[t(5;11)(q31;q23) KMT2A/ARHGAP26]]
 
: [[t(5;12)(q13;p13) ?/ETV6]]
 
: [[t(5;12)(q31;p13) ETV6/ACSL6 in MDS,AML and AEL]]
 
: [[t(5;12)(q33;p13) ETV6/PDGFRB]]
 
: [[t(5;16)(q32;p13) NDE1/PDGFRB]]
 
: [[t(5;17)(q33;p11.2) SPECC1/PDGFRB]]
 
: [[t(5;17)(q33;p13) RABEP1/PDGFRB]]
 
: [[t(5;21)(q13;q22) RUNX1/?]]
 
: [[t(5;7)(q33;q11) HIP1/PDGFRB]]
 
: [[t(6;12)(p21;p13) CCND3/ETV6 in lymphoid malignancies]]
 
: [[t(6;20)(q13;q12) LMBRD1/CHD6]]
 
: [[t(6;21)(p22;q22) RUNX1-?]]
 
: [[t(6;8)(q27;p12) FGFR1OP/FGFR1]]
 
: [[t(6;9)(p22;q34) DEK/NUP214]]
 
: [[t(7;12)(p12;q13) HMGA2 truncated]]
 
: [[t(7;12)(q36;p13) MNX1/ETV6]]
 
: [[t(8;12)(q12;p13)]]
 
: [[t(8;12)(q22;q13) HMGA2/?]]
 
: [[t(8;13)(p11;q12) ZMYM2/FGFR1]]
 
: [[t(8;21)(q23;q22) RUNX1/ZFPM2]]
 
: [[t(8;9)(p22;p24) PCM1/JAK2]]
 
: [[t(9;12)(p24;p13) ETV6/JAK2]]
 
: [[t(9;12)(q22;p12) ETV6/SYK]]
 
: [[t(9;12)(q34;p13) ETV6/ABL1]]
 
: [[t(X;20)(q13;q13.3)]]
 
: [[t(Y;1)(q12;q12)]]
 
  
==Treatment Related Leukaemias (t-ANLL)==
+
{| class="wikitable"
 +
|+INVERSIONS
 +
|-
 +
|'''ANOMALY'''
 +
|'''ASSOCIATED DISORDERS with FISH test'''
 +
|'''GENES'''
 +
|-
 +
|[[inv(3)(q21q26.2) ]]
 +
|[[MDS]],[[ AML]]
 +
|[[RPN1-MECOM(EVI1)]]
 +
|-
 +
|[[inv(11)(q21q23)  ]]
 +
|[[MDS]],[[ AML M2]],[[ T-ALL]]
 +
|[[MAML2-MLL]]
 +
|-
 +
|[[inv(14)(q11.2q32) ]]
 +
|[[PLL]]
 +
|[[TRA-TCL1A(TCL1)]]
 +
|-
 +
|[[inv(16)(p13.1q22)]]
 +
|[[AML M4Eo]]
 +
|[[MYH11]],[[ CBFB]]
 +
|}
  
: [[+11 or trisomy 11 (solely) KMT2A]]
+
==Duplications==
: [[+20 or trisomy 20 (solely)]]
 
: [[+4 or trisomy 4]]
 
: [[+8 or trisomy 8]]
 
: [[-7/del(7q) in adults]]
 
: [[-7/del(7q) in childhood]]
 
: [[11p15 rearrangements (NUP98) in treatment related leukemia]]
 
: [[11q23 rearrangements (KMT2A) in leukaemia]]
 
: [[11q23 rearrangements (KMT2A) in therapy related leukaemias]]
 
: [[12p abnormalities in myeloid malignancies]]
 
: [[12p13 rearrangements (ETV6) in treatment related leukemia]]
 
: [[21q22 rearrangements (RUNX1) in treatment related leukemia]]
 
: [[3q21q26 rearrangements (RPN1/MECOM) in treatment related leukemia]]
 
: [[Biphenotypic Acute Leukaemia (BAL)]]
 
: [[Childhood myelodysplastic syndromes]]
 
: [[Classification of acute myeloid leukemias]]
 
: [[Classification of myelodysplasic syndromes]]
 
: [[MLL amplification in leukemia]]
 
: [[del(13q) in myeloid malignancies]]
 
: [[del(16)(q22) CBFB/MYH11]]
 
: [[del(17p) in myeloid malignancies]]
 
: [[del(5q) in myeloid neoplasms]]
 
: [[dic(17;20)(p11.2;q11.2)]]
 
: [[inv(11)(q21q23) KMT2A/MAML2 in therapy related leukemias]]
 
: [[inv(16)(p13q22) CBFB/MYH11]]
 
: [[inv(16)(p13q22) CBFB/MYH11 in treatment related leukemia]]
 
: [[inv(6)(p15q13)]]
 
: [[t(10;11)(p12;q23) KMT2A/MLLT10]]
 
: [[t(11;11)(q13;q23) KMT2A/ARHGEF17]]
 
: [[t(11;12)(p15;q13) NUP98/?]]
 
: [[t(11;12)(q23;q13) /HMGA2]]
 
: [[t(11;14)(q23;q32) KMT2A/CEP170B]]
 
: [[t(11;15)(q23;q14) KMT2A/CASC5]]
 
: [[t(11;16)(q23;p13.3) KMT2A/CREBBP]]
 
: [[t(11;17)(q23;p13) KMT2A/GAS7]]
 
: [[t(11;17)(q23;q25) KMT2A/SEPT9]]
 
: [[t(11;19)(q23;p13.1) KMT2A/ELL]]
 
: [[t(11;19)(q23;p13.3) KMT2A/MLLT1]]
 
: [[t(11;20)(p15;q11) NUP98/TOP1]]
 
: [[t(11;22)(q23;q13) KMT2A/EP300]]
 
: [[t(12;13)(p13;q14) LIN00598/ETV6]]
 
: [[t(12;21)(q24;q22) RUNX1/?]]
 
: [[t(14;21)(q22;q22) RUNX1/?]]
 
: [[t(15;17)(q22;q21) in treatment related leukemia]]
 
: [[t(15;17)(q24;q21) PML/RARA]]
 
: [[t(15;21)(q22;q22) RUNX1/?]]
 
: [[t(16;16)(p13;q22) CBFB/MYH11]]
 
: [[t(16;21)(q24;q22) RUNX1/CBFA2T3]]
 
: [[t(17;21)(q11.2;q22) RUNX1/?]]
 
: [[t(18;21)(q21;q22) RUNX1/?]]
 
: [[t(19;21)(q13.4;q22) RUNX1 truncated]]
 
: [[t(1;11)(q23;p15) NUP98/PRRX1]]
 
: [[t(1;12)(q21;q24)]]
 
: [[t(1;21)(p22;q22) RUNX1/CLCA2]]
 
: [[t(1;21)(p36;q22) RUNX1/PRDM16]]
 
: [[t(1;3)(p36;p21)]]
 
: [[t(1;3)(p36;q21) PSMD2/PRDM16]]
 
: [[t(1;6)(p36;p21)]]
 
: [[t(1;7)(p36;q34)]]
 
: [[t(1;7)(q10;p10)]]
 
: [[t(2;11)(q31;p15) NUP98/HOXD11]]
 
: [[t(2;11)(q31;p15) NUP98/HOXD13]]
 
: [[t(2;11)(q37;q23) KMT2A/SEPT2]]
 
: [[t(2;19)(p11;p13)]]
 
: [[t(2;3)(p15-23;q26-27) ?/MECOM]]
 
: [[t(2;3)(p15-23;q26-27) ?/MECOM]]
 
: [[t(2;8)(p23;p11) KAT6A/ASXL2]]
 
: [[t(3;11)(p21;q23) KMT2A/NCKIPSD]]
 
: [[t(3;11)(q25;q23) KMT2A/GMPS]]
 
: [[t(3;11)(q28;q23) KMT2A/LPP]]
 
: [[t(3;12)(q26;q21) ?/MECOM]]
 
: [[t(3;17)(q26;q22) ?/MECOM]]
 
: [[t(3;21)(q26;q22) RUNX1/MECOM]]
 
: [[t(3;21)(q26;q22) RUNX1/MECOM in treatment related leukemia]]
 
: [[t(3;6)(q25;q26) ?/MECOM]]
 
: [[t(4;11)(p12;q23) KMT2A/FRYL]]
 
: [[t(4;11)(q21;q23) KMT2A/AFF1]]
 
: [[t(4;12)(q12;p13) CHIC2/ETV6]]
 
: [[t(5;11)(q31;q23) KMT2A/ARHGAP26]]
 
: [[t(6;11)(q27;q23) KMT2A/MLLT4]]
 
: [[t(6;21)(p22;q22) RUNX1-?]]
 
: [[t(6;9)(p22;q34) DEK/NUP214]]
 
: [[t(8;16)(p11;p13) KAT6A/CREBBP]]
 
: [[t(8;16)(p11;p13) KAT6A/CREBBP in treatment related leukemia]]
 
: [[t(8;21)(q22;q22) RUNX1/RUNX1T1]]
 
: [[t(8;21)(q22;q22) RUNX1/RUNX1T1 in treatment related leukemia]]
 
: [[t(9;11)(p22;q23) KMT2A/MLLT3]]
 
: [[t(9;21)(p22;q22)]]
 
: [[t(9;22)(q34;q11) BCR/ABL1 in treatment related leukemia]]
 
  
==Acute Non Lymphocytic Leukaemias (ANLL)==
+
{| class="wikitable"
 +
|+DUPLICATIONS
 +
|-
 +
|'''ANOMALY'''
 +
|'''ASSOCIATED DISORDERS with FISH test'''
 +
|'''GENES'''
 +
|-
 +
|[[dup(1)(q11q44) ]]
 +
|-
 +
|[[dup(1)(q21q32) ]]
 +
|[[B-ALL]],[[ NHL]]
 +
|-
 +
|[[dup(1)(q21q42)]]
 +
|-
 +
|[[dup(1)(q23q32)]]
 +
|-
 +
|[[dup(1)(q23q42)]]
 +
|[[NHL ]]
 +
|-
 +
|[[dup(11)(q13q25)]]
 +
|[[NHL ]]
 +
|[[MLL]]
 +
|-
 +
|[[dup(12)(q13q22)]]
 +
|}
  
: [[+10 or trisomy 10 (solely)]]
 
: [[+11 or trisomy 11 (solely) KMT2A]]
 
: [[+13 or trisomy 13]]
 
: [[+13,+13 or tetrasomy 13]]
 
: [[+14 or trisomy 14 (solely)]]
 
: [[+15 or trisomy 15 (as sole autosomal abnormality)]]
 
: [[+16 or trisomy 16 (solely)]]
 
: [[+18 or trisomy 18 in lymphoproliferative disorders]]
 
: [[+21 or trisomy 21]]
 
: [[+22 or trisomy 22 (solely?)]]
 
: [[+4 or trisomy 4]]
 
: [[+6 or trisomy 6]]
 
: [[+7 or trisomy 7 (solely)]]
 
: [[+8 or trisomy 8]]
 
: [[+9 or trisomy 9]]
 
: [[-21 or monosomy 21 (solely)]]
 
: [[-7/del(7q) in adults]]
 
: [[-7/del(7q) in childhood]]
 
: [[11q23 rearrangements (KMT2A) in de novo childhood acute myeloid leukemia]]
 
: [[11q23 rearrangements (KMT2A) in leukaemia]]
 
: [[12p abnormalities in myeloid malignancies]]
 
: [[15q13-15 Rearrangements]]
 
: [[1q translocations (unbalanced) in myeloid malignancies]]
 
: [[1q triplication in hematologic malignancies]]
 
: [[3q26 rearrangements (MECOM) in myeloid malignancies]]
 
: [[Acute Erythroid leukaemias]]
 
: [[Acute basophilic leukemia]]
 
: [[Acute megakaryoblastic leukemia (AMegL)]]
 
: [[Acute promyelocytic leukemia (APL)]]
 
: [[Biphenotypic Acute Leukaemia (BAL)]]
 
: [[Classification of acute myeloid leukemias]]
 
: [[Congenital leukaemias]]
 
: [[Infant leukaemias]]
 
: [[Isolated tetrasomy 8 in AML, MDS and MPD]]
 
: [[M0 acute non lymphocytic leukemia (M0-ANLL)]]
 
: [[M3/M3v acute myeloid leukemia (AML M3/M3v)]]
 
: [[M3/M3v acute non lymphocytic leukemia (M3-ANLL)]]
 
: [[M7 acute non lymphocytic leukemia (M7-ANLL)]]
 
: [[MLL amplification in leukemia]]
 
: [[Monosomal karyotype (MK) in myeloid malignancies]]
 
: [[Neonatal leukaemias]]
 
: [[Systemic mast cell disease (SMCD)]]
 
: [[Trisomy 19]]
 
: [[Trisomy 2]]
 
: [[Trisomy 5]]
 
: [[Y loss in leukemia]]
 
: [[del (13q)]]
 
: [[del(11)(q23q23) KMT2A/ARHGEF12]]
 
: [[del(11)(q23q23) KMT2A/CBL]]
 
: [[del(16)(q22) CBFB/MYH11]]
 
: [[del(17)(q21q24) PRKAR1A/RARA]]
 
: [[del(17p) in myeloid malignancies]]
 
: [[del(20q) in myeloid malignancies]]
 
: [[del(21)(q21q22) USP16/RUNX1]]
 
: [[del(4)(q12q12) FIP1L1/PDGFRA]]
 
: [[del(5q) in myeloid neoplasms]]
 
: [[del(9q) solely]]
 
: [[dic(17;20)(p11.2;q11.2)]]
 
: [[dic(1;15)(p11;p11)]]
 
: [[dup(17)(q12q21) STAT5B/RARA]]
 
: [[i(5)(p10) in acute myeloid leukemia]]
 
: [[i(8)(q10) in acute myeloid leukaemia]]
 
: [[ider(20q) in Myeloid Malignancies]]
 
: [[idic(7)(q11.2)]]
 
: [[idic(X)(q13)]]
 
: [[ins(3;3)(q26;q21q26) PSMD2/MECOM]]
 
: [[ins(X;11)(q26;q23q23)]]
 
: [[inv(11)(p15q22) NUP98/DDX10]]
 
: [[inv(12)(p13q15) ETV6/PTPRR]]
 
: [[inv(14)(q11q32.1) TRA-TRD/TCL1A]]
 
: [[inv(16)(p13q22) CBFB/MYH11]]
 
: [[inv(16)(p13q24) CBFA2T3/GLIS2]]
 
: [[inv(2)(p23q13) RANBP2/ALK]]
 
: [[inv(3)(q21q26) PSMD2/MECOM]]
 
: [[inv(3)(q21q26) PSMD2/MECOM]]
 
: [[inv(6)(p25q13)]]
 
: [[inv(8)(p11q13) KAT6A/NCOA2]]
 
: [[t(10;11)(p11.2;q23) KMT2A/ABI1]]
 
: [[t(10;11)(p12;q23) KMT2A/MLLT10]]
 
: [[t(10;11)(p12;q23) KMT2A/NEBL]]
 
: [[t(10;11)(p13;q21) PICALM/MLLT10]]
 
: [[t(10;11)(q22;q23) KMT2A/TET1]]
 
: [[t(10;16)(q22;p13) KAT6B/CREBBP]]
 
: [[t(10;17)(p15;q21) ZMYND11/MBTD1]]
 
: [[t(11;11)(p15;q22) NUP98/DDX10]]
 
: [[t(11;11)(q23;q23) KMT2A/CBL]]
 
: [[t(11;12)(p15;p13) NUP98/KDM5A]]
 
: [[t(11;12)(q23;q13) KMT2A/SARNP]]
 
: [[t(11;16)(q23;p13.3) KMT2A/CREBBP]]
 
: [[t(11;17)(p15;p13) NUP98/PHF23]]
 
: [[t(11;17)(q13;q21) NUMA1/RARA]]
 
: [[t(11;17)(q23;p13) KMT2A/GAS7]]
 
: [[t(11;17)(q23;q12) KMT2A/RARA]]
 
: [[t(11;17)(q23;q12-21) KMT2A/LASP1]]
 
: [[t(11;17)(q23;q12-21) KMT2A/MMLT6]]
 
: [[t(11;17)(q23;q21) ZBTB16/RARA]]
 
: [[t(11;17)(q23;q25) KMT2A/SEPT9]]
 
: [[t(11;19)(q23;p13) KMT2A/SH3GL1]]
 
: [[t(11;19)(q23;p13.1) KMT2A/ELL]]
 
: [[t(11;19)(q23;p13.3) KMT2A/MLLT1]]
 
: [[t(11;20)(p15;q11) NUP98/TOP1]]
 
: [[t(11;21)(p14;q22) RUNX1/KIAA1549L]]
 
: [[t(11;21)(q13;q22) RUNX1/MACROD1]]
 
: [[t(11;21)(q21;q22) RUNX1/LPXN]]
 
: [[t(11;22)(q23;q11.2) KMT2A/SEPT5]]
 
: [[t(12;12)(p13;q13) ETV6/BAZ2A]]
 
: [[t(12;13)(p12;q12-14) ETV6/CDX2]]
 
: [[t(12;13)(p13;q14) LIN00598/ETV6]]
 
: [[t(12;15)(p13;q25) ETV6/NTRK3]]
 
: [[t(12;17)(p11;q11) in AML]]
 
: [[t(12;17)(p13;p13) ETV6/PER1]]
 
: [[t(12;17)(p13;q11) TAF15/ZNF384]]
 
: [[t(12;18)(p13;q12) ETV6/SETBP1]]
 
: [[t(12;19)(q13;q13)]]
 
: [[t(12;21)(q12;q22) RUNX1 truncated]]
 
: [[t(12;22)(p13;q12) EWSR1/ZNF384]]
 
: [[t(12;22)(p13;q12) MN1/ETV6]]
 
: [[t(14;14)(q11;q32.1) TRA-TRD/TCL1A]]
 
: [[t(14;22)(q32;q11) IGH/IGL]]
 
: [[t(15;17)(q24;q21) PML/RARA]]
 
: [[t(16;16)(p13;q22) CBFB/MYH11]]
 
: [[t(16;21)(p11;q22) FUS/ERG]]
 
: [[t(16;21)(q24;q22) RUNX1/CBFA2T3]]
 
: [[t(17;17)(q21;q21) STAT5B/RARA]]
 
: [[t(17;17)(q21;q24) PRKAR1A/RARA]]
 
: [[t(17;21)(q11.2;q22) RUNX1/?]]
 
: [[t(1;11)(p32;q23) KMT2A/EPS15]]
 
: [[t(1;11)(q21;q23) KMT2A/MLLT11]]
 
: [[t(1;12)(q21;q24)]]
 
: [[t(1;12)(q25;p13) ETV6/ABL2]]
 
: [[t(1;14)(q25;q32) IGH/LHX4]]
 
: [[t(1;16)(q12;q24)]]
 
: [[t(1;18)(q25;q23)]]
 
: [[t(1;19)(p13;p13.1)]]
 
: [[t(1;19)(q23;p13) TCF3/PBX1]]
 
: [[t(1;2)(q12;q37)]]
 
: [[t(1;21)(p32;q22) RUNX1/?]]
 
: [[t(1;21)(p35;q22) RUNX1/YTHDF2]]
 
: [[t(1;21)(p36;q22) RUNX1/PRDM16]]
 
: [[t(1;21)(q12;q22) RUNX1/?]]
 
: [[t(1;21)(q21;q22) RUNX1/ZNF687]]
 
: [[t(1;22)(p13;q13) RBM15/MKL1]]
 
: [[t(1;3)(p36;p21)]]
 
: [[t(1;3)(p36;q21) PSMD2/PRDM16]]
 
: [[t(1;7)(p36;q34)]]
 
: [[t(1;7)(q10;p10)]]
 
: [[t(1;8)(p22-p32;q22-q23)]]
 
: [[t(20;21)(q11;q22) RUNX1/?]]
 
: [[t(20;21)(q13;q22) RUNX1/?]]
 
: [[t(2;11)(p21;q23) KMT2A/?]]
 
: [[t(2;11)(q31;p15) NUP98/HOXD11]]
 
: [[t(2;11)(q31;p15) NUP98/HOXD13]]
 
: [[t(2;11)(q37;q23) KMT2A/SEPT2]]
 
: [[t(2;14)(p13-16;q32) IGH/BCL11A]]
 
: [[t(2;19)(p11;p13)]]
 
: [[t(2;2)(p23;q13) RANBP2/ALK]]
 
: [[t(2;21)(p11;q22) RUNX1/?]]
 
: [[t(2;3)(p15-23;q26-27) ?/MECOM]]
 
: [[t(2;3)(p16;q26) BCL11A/MECOM]]
 
: [[t(2;3)(p21;q26) THADA/MECOM]]
 
: [[t(2;4)(p23;q25-q35)]]
 
: [[t(3;11)(p25;p15) ANKRD28/NUP98]]
 
: [[t(3;11)(q12;p15) NUP98/LNP1]]
 
: [[t(3;11)(q13.13;q23) KMT2A/KIAA1524]]
 
: [[t(3;12)(q26;p13) ETV6/EVI1]]
 
: [[t(3;12)(q26;p13) ETV6/MECOM]]
 
: [[t(3;16)(q21;q22)]]
 
: [[t(3;17)(q26;q22) ?/MECOM]]
 
: [[t(3;21)(p12;q22) RUNX1/?]]
 
: [[t(3;21)(q26;q22) RUNX1/MECOM]]
 
: [[t(3;3)(q21;q26) PSMD2/MECOM]]
 
: [[t(3;4)(p21;q34)]]
 
: [[t(3;5)(p21;q32) RBM6/CSF1R]]
 
: [[t(3;5)(q21;q31)]]
 
: [[t(3;5)(q25;q34) NPM1/MLF1]]
 
: [[t(3;5)(q26;q34) ?/MECOM]]
 
: [[t(3;6)(q25;q26) ?/MECOM]]
 
: [[t(3;7)(q26;q21) MECOM/CDK6]]
 
: [[t(3;8)(q21;q24) in myeloid malignancies]]
 
: [[t(3;8)(q26;q24) PVT1/MECOM]]
 
: [[t(4;11)(q21;q23) KMT2A/AFF1]]
 
: [[t(4;11)(q35;q23) KMT2A/SORBS2]]
 
: [[t(4;12)(q12;p13) CHIC2/ETV6]]
 
: [[t(4;17)(q12;q21) FIP1L1/RARA]]
 
: [[t(4;21)(q31;q22) RUNX1/SH3D19]]
 
: [[t(4;5)(q31;q31)]]
 
: [[t(5;11)(q31;q23) KMT2A/ARHGAP26]]
 
: [[t(5;11)(q35;p15.5) NUP98/NSD1]]
 
: [[t(5;11)(q35;q12) NSD1/FEN1]]
 
: [[t(5;12)(p13;p13) NIPBL/ETV6]]
 
: [[t(5;12)(q13;p13) ?/ETV6]]
 
: [[t(5;12)(q31;p13) ETV6/ACSL6 in MDS,AML and AEL]]
 
: [[t(5;12)(q33;p13) ERC1/PDGFRB]]
 
: [[t(5;14)(q33;q32) PDGFRB/TRIP11]]
 
: [[t(5;14)(q35;q11) TRD/NKX2-5]]
 
: [[t(5;16)(q33;q22)]]
 
: [[t(5;17)(q35;q21) NPM1/RARA]]
 
: [[t(5;21)(q13;q22) RUNX1/?]]
 
: [[t(6;11)(q13;q23) KMT2A-SMAP1]]
 
: [[t(6;11)(q15;q23) KMT2A/?]]
 
: [[t(6;11)(q27;q23) KMT2A/MLLT4]]
 
: [[t(6;14)(q25-27;q32) BCL11B/?]]
 
: [[t(6;20)(q13;q12) LMBRD1/CHD6]]
 
: [[t(6;22)(p21;q11)]]
 
: [[t(6;8)(q27;p12) FGFR1OP/FGFR1]]
 
: [[t(6;9)(p22;q34) DEK/NUP214]]
 
: [[t(7;11)(p15;p15) NUP98/HOXA9]]
 
: [[t(7;12)(q36;p13) MNX1/ETV6]]
 
: [[t(7;14)(q21;q13)]]
 
: [[t(7;14)(q22;q11)]]
 
: [[t(7;14)(q35;q32.1) TRB/TCL1A]]
 
: [[t(7;21)(p15;q22) RUNX1/?]]
 
: [[t(7;21)(p22;q22) RUNX1/USP42]]
 
: [[t(7;8)(q34;p11) TRIM24/FGFR1]]
 
: [[t(8;11)(p11;p15) NUP98/WHSC1L1]]
 
: [[t(8;11)(p12;p15) ?/FGFR1]]
 
: [[t(8;12)(q12;p13)]]
 
: [[t(8;12)(q13;p13) ETV6/NCOA2]]
 
: [[t(8;16)(p11;p13) KAT6A/CREBBP]]
 
: [[t(8;19)(p11;q13) ERVK-6/FGFR1]]
 
: [[t(8;19)(p11;q13) KAT6A/?]]
 
: [[t(8;20)(p11;q13) KAT6A/NCOA3]]
 
: [[t(8;21)(q22;q22) RUNX1/RUNX1T1]]
 
: [[t(8;21)(q24;q22) RUNX1/TRPS1]]
 
: [[t(8;22)(p11;q13) KAT6A/EP300]]
 
: [[t(8;9)(p22;p24) PCM1/JAK2]]
 
: [[t(9;11)(p22;p15) NUP98/PSIP1]]
 
: [[t(9;11)(p22;q23) KMT2A/MLLT3]]
 
: [[t(9;11)(q34;p15) NUP98/PRRX2]]
 
: [[t(9;11)(q34;q23) FNBP1/KMT2A]]
 
: [[t(9;11)(q34;q23) KMT2A/DAB2IP]]
 
: [[t(9;12)(q34;p13) ETV6/ABL1]]
 
: [[t(9;21)(q34;q22) RUNX1 truncated]]
 
: [[t(9;22)(q34;q11) BCR/ABL1 in AML]]
 
: [[t(9;9)(q34;q34) SET/NUP214]]
 
: [[t(X;10)(p10;p10)]]
 
: [[t(X;11)(q13;q23) KMT2A/FOXO4]]
 
: [[t(X;11)(q22;q23) KMT2A/?]]
 
: [[t(X;11)(q24;q23) KMT2A/SEPT6]]
 
: [[t(X;11)(q26;q23)]]
 
: [[t(X;17)(p11;q21) BCOR/RARA]]
 
: [[t(X;21)(p22;q22) RUNX1/RPL22]]
 
: [[t(X;21)(q26;q22) ELF4/ERG]]
 
: [[t(X;6)(p11;q23) MYB/GATA1]]
 
  
==B-Cell Acute Lymphocytic Leukaemias (B-ALL)==
+
==Isochromsomes==
  
: [[+10 or trisomy 10 (solely)]]
+
{| class="wikitable"
: [[+13 or trisomy 13]]
+
|+ISOCHROMOSOMES
: [[+15 or trisomy 15 (as sole autosomal abnormality)]]
+
|-
: [[+16 or trisomy 16 (solely)]]
+
|'''ANOMALY'''
: [[+18 or trisomy 18 in lymphoproliferative disorders]]
+
|'''ASSOCIATED DISORDERS with FISH test'''
: [[+21 or trisomy 21]]
+
|'''GENES'''
: [[+4 or trisomy 4]]
+
|-
: [[+6 or trisomy 6]]
+
|[[i(1)(q10)]]
: [[+8 or trisomy 8]]
+
|[[NHL ]]
: [[+9 or trisomy 9]]
+
|-
: [[-21 or monosomy 21 (solely)]]
+
|[[i(3)(q10)]]
: [[11q23 rearrangements (KMT2A) in childhood acute lymphoblastic leukemia]]
+
|[[NHL ]]
: [[11q23 rearrangements (KMT2A) in leukaemia]]
+
|-
: [[12p rearrangements (ETV6) in ALL]]
+
|[[i(7)(q10) ]]
: [[15q13-15 Rearrangements]]
+
|[[T-cell lymphoma]]
: [[9p Rearrangements in ALL]]
+
|-
: [[Biphenotypic Acute Leukaemia (BAL)]]
+
|[[i(8)(q10)]]
: [[Congenital leukaemias]]
+
|[[T-PLL]],[[ AML]],[[ B-ALL]]
: [[High hyperdiploid acute lymphoblastic leukaemia]]
+
|-
: [[Infant leukaemias]]
+
|[[i(11)(q10) ]]
: [[Near haploid acute lymphoblastic leukaemia]]
+
|[[AML M2]],[[ M4]],[[ MDS]]
: [[Neonatal leukaemias]]
+
|-
: [[Severe hypodiploid acute lymphoblastic leukaemia]]
+
|[[i(17)(q10)]]
: [[Trisomy 5]]
+
|[[MDS]],[[ MPD]],[[ AML]],[[ CML]],[[ B-ALL]],[[ CLL]],[[ Hodgkin and NHL]]
: [[del(13q) in ALL]]
+
|-
: [[del(6q) abnormalities in lymphoid malignancies]]
+
|[[i(21)(q10)]]
: [[del(9)(p13p24) PAX5/JAK2]]
+
|[[B-ALL]],[[ MDS]],[[ NHL]],[[ AML]],[[ CMML]]
: [[dic(3;9)(p14;p13) PAX5/FOXP1]]
+
|-
: [[dic(7;9)(p11-12;p12-13) PAX5/LOC392027]]
+
|[[idic(X)(q13)]]
: [[dic(7;9)(p11-13;p11)]]
+
|[[AML M1]],[[ M2]],[[ M4]],[[ MDS]],[[ RARS]]
: [[dic(9;12)(p13;p12) PAX5/SLCO1B3]]
+
|[[XIST]]
: [[dic(9;12)(p13;p13) PAX5/ETV6]]
+
|}
: [[dic(9;16)(p13;q11) PAX5/?]]
 
: [[dic(9;17)(p13;q11) PAX5/TAOK1]]
 
: [[dic(9;18)(p13;q11) PAX5/ZNF521]]
 
: [[dic(9;20)(p11-13;q11) PAX5/Various]]
 
: [[dup(21q) amplified (RUNX1)]]
 
: [[i(6)(p10)]]
 
: [[i(9q) in ALL]]
 
: [[ins(5;11)(q31;q13q23) KMT2A/AFF4]]
 
: [[ins(X;11)(q26;q23q23)]]
 
: [[inv(11)(q13q23) KMT2A/BTBD18]]
 
: [[inv(14)(q11q32) CEBPE/IGH]]
 
: [[inv(14)(q11q32.1) TRA-TRD/TCL1A]]
 
: [[inv(19)(p13q13) TCF3/TFPT]]
 
: [[inv(9)(p13p24) PAX5/JAK2]]
 
: [[t(10;11)(p12;q23) KMT2A/MLLT10]]
 
: [[t(10;11)(p13;q21) PICALM/MLLT10]]
 
: [[t(10;11)(q22;q23) KMT2A/TET1]]
 
: [[t(11;16)(q23;p13.3) KMT2A/CREBBP]]
 
: [[t(11;17)(q23;p13) KMT2A/GAS7]]
 
: [[t(11;17)(q23;q25) KMT2A/SEPT9]]
 
: [[t(11;19)(q23;p13.3) KMT2A/ACER1]]
 
: [[t(11;19)(q23;p13.3) KMT2A/MLLT1]]
 
: [[t(11;20)(q23;q11) KMT2A/MAPRE1]]
 
: [[t(12;12)(p13;q13) ETV6/BAZ2A]]
 
: [[t(12;13)(p12;q12-14) ETV6/CDX2]]
 
: [[t(12;13)(p13;q14) LIN00598/ETV6]]
 
: [[t(12;14)(p13;q32) IGH/ETV6]]
 
: [[t(12;17)(p13;q11) TAF15/ZNF384]]
 
: [[t(12;17)(p13;q11-21) in ALL]]
 
: [[t(12;19)(p13;p13) TCF3/ZNF384]]
 
: [[t(12;21)(p13;q22) ETV6/RUNX1]]
 
: [[t(12;22)(p13;q12) EWSR1/ZNF384]]
 
: [[t(13;19)(q14;p13) TCF3/?]]
 
: [[t(14;14)(q11;q32) CEBPE/IGH]]
 
: [[t(14;14)(q11;q32.1) TRA-TRD/TCL1A]]
 
: [[t(14;18)(q32;q21) IGH/BCL2]]
 
: [[t(14;19)(q32;q13) IGH/CEBPA]]
 
: [[t(14;20)(q32;q13) IGH/CEBPB]]
 
: [[t(17;19)(q22;p13) TCF3/HLF]]
 
: [[t(18;22)(q21;q11) IGL/BCL2]]
 
: [[t(19;19)(p13;q13) TCF3/TFPT]]
 
: [[t(1;11)(p32;q23) KMT2A/EPS15]]
 
: [[t(1;14)(q21;q32)]]
 
: [[t(1;14)(q21;q32) BCL9/IGH]]
 
: [[t(1;14)(q25;q32) IGH/LHX4]]
 
: [[t(1;18)(q25;q23)]]
 
: [[t(1;19)(q23;p13) TCF3/PBX1]]
 
: [[t(1;2)(q12;q37)]]
 
: [[t(1;22)(q21;q11)]]
 
: [[t(1;22)(q21;q11) IGL/BCL9]]
 
: [[t(1;3)(p36;p21)]]
 
: [[t(1;5)(q22;q33) PDE4DIP/PDGFRB]]
 
: [[t(1;9)(p13;p12) PAX5/HIPK1]]
 
: [[t(1;9)(p34;q34) SFPQ/ABL1]]
 
: [[t(1;9)(q24;q34) RCSD1/ABL1]]
 
: [[t(2;11)(p21;q23) KMT2A/?]]
 
: [[t(2;14)(p13-16;q32) IGH/BCL11A]]
 
: [[t(2;18)(p11;q21) IGK/BCL2]]
 
: [[t(2;8)(p12;q24) IGK/MYC]]
 
: [[t(2;9)(p11;p13) PAX5/?]]
 
: [[t(2;9)(q37;q34) INPP5D-ABL1]]
 
: [[t(3;11)(q21;q23) KMT2A/EEFSEC]]
 
: [[t(4;11)(p12;q23) KMT2A/FRYL]]
 
: [[t(4;11)(q21;q23) KMT2A/AFF1]]
 
: [[t(4;12)(q12;p13) CHIC2/ETV6]]
 
: [[t(5;11)(q31;q23) KMT2A/ARHGAP26]]
 
: [[t(5;14)(q31;q32) IGH/IL3]]
 
: [[t(5;15)(p15;q11-13)]]
 
: [[t(5;9)(q14.1;p24) SSBP2/JAK2]]
 
: [[t(6;12)(p21;p13) CCND3/ETV6 in lymphoid malignancies]]
 
: [[t(6;14)(p22;q32) IGH/ID4]]
 
: [[t(6;14)(q25-27;q32) BCL11B/?]]
 
: [[t(6;22)(p21;q11)]]
 
: [[t(7;12)(q36;p13) MNX1/ETV6]]
 
: [[t(7;14)(q35;q32.1) TRB/TCL1A]]
 
: [[t(7;9)(q11.2;p13.2) PAX5/AUTS2]]
 
: [[t(7;9)(q11;p12) PAX5/POM121]]
 
: [[t(7;9)(q11;p13) PAX5/ELN]]
 
: [[t(8;12)(q13;p13) ETV6/NCOA2]]
 
: [[t(8;14)(q11;q32) IGH/CEBPD]]
 
: [[t(8;14)(q24;q11) TRA/MYC]]
 
: [[t(8;14)(q24;q32) IGH/MYC]]
 
: [[t(8;22)(q24;q11) IGL/MYC]]
 
: [[t(8;9)(p22;p24) PCM1/JAK2]]
 
: [[t(8;9)(q24;p13) ?/MYC]]
 
: [[t(8;9)(q24;q13)]]
 
: [[t(9;10)(q34;q22) ZMIZ1/ABL1]]
 
: [[t(9;12)(p24;p13) ETV6/JAK2]]
 
: [[t(9;12)(q34;p13) ETV6/ABL1]]
 
: [[t(9;13)(p12;q21) PAX5/DACH1]]
 
: [[t(9;15)(p13;q24) PAX5/GOLGA6A]]
 
: [[t(9;15)(p13;q24) PAX5/PML]]
 
: [[t(9;17)(p13;p12) PAX5/NCOR1]]
 
: [[t(9;22)(p13;q13) PAX5/BRD1]]
 
: [[t(9;22)(q34;q11) BCR/ABL1 in ALL]]
 
: [[t(9;9)(p13;p24) PAX5/JAK2]]
 
: [[t(X;11)(q22;q23) KMT2A/?]]
 
: [[t(X;11)(q26;q23)]]
 
: [[t(X;9)(q21;p13) PAX5/DACH2]]
 
  
==T-Cell Acute Lymphocytic Leukaemias (T-ALL)==
+
==Cryptic==
  
: [[+20 or trisomy 20 (solely)]]
+
{| class="wikitable"
: [[+4 or trisomy 4]]
+
|+CRYPTIC
: [[+7 or trisomy 7 (solely)]]
+
|-
: [[+8 or trisomy 8]]
+
|'''ANOMALY'''
: [[+9 or trisomy 9]]
+
|'''ASSOCIATED DISORDERS with FISH test'''
: [[11q23 rearrangements (KMT2A) in childhood acute lymphoblastic leukemia]]
+
|'''GENES'''
: [[11q23 rearrangements (KMT2A) in leukaemia]]
+
|-
: [[12p rearrangements (ETV6) in ALL]]
+
|[[t(12;21)(p13;q22)]]
: [[15q13-15 Rearrangements]]
+
|[[B-ALL]]
: [[1p32 rearrangements]]
+
|[[ETV6 (TEL)-RUNX1(AML1)]]
: [[9p Rearrangements in ALL]]
+
|-
: [[Biphenotypic Acute Leukaemia (BAL)]]
+
|[[t(X;14)]]
: [[NK cell neoplasias]]
+
|[[B-ALL]]
: [[NUP214/ABL1 fusion gene on amplified episomes]]
+
|[[CRLF2-IGH]]
: [[T-lineage acute lymphoblastic leukemia (T-ALL)]]
+
|-
: [[del(11)(p12p13) LMO2]]
+
|[[t(Y;14)]]
: [[del(13q) in ALL]]
+
|[[B-ALL]]
: [[del(6q) abnormalities in lymphoid malignancies]]
+
|[[CRLF2-IGH]]
: [[del(9q) solely]]
+
|-
: [[dic(9;12)(p13;p13) PAX5/ETV6]]
+
|[[t(5;14)(q35;q32)]]
: [[i(6)(p10)]]
+
|[[T-ALL]]
: [[inv(14)(q11q32.1) TRA-TRD/TCL1A]]
+
|[[TLX3-BCL11B]]
: [[inv(7)(p15q34) TRB/HOXA10]]
+
|-
: [[t(10;11)(p13;q21) PICALM/MLLT10]]
+
|[[del(1)(p32p32)]]
: [[t(10;11)(q25;p15) NUP98/ADD3]]
+
|[[B-ALL]]
: [[t(10;14)(q24;q11) TRD/TLX1]]
+
|[[TAL1-STIL]]
: [[t(11;14)(p13;q11) TRD/LMO2]]
+
|}
: [[t(11;14)(p15;q11) TRD/LMO1]]
 
: [[t(11;18)(p15;q12) NUP98/SETBP1]]
 
: [[t(11;19)(q23;p13.3) KMT2A/MLLT1]]
 
: [[t(12;12)(p13;q13) ETV6/BAZ2A]]
 
: [[t(12;13)(p12;q12-14) ETV6/CDX2]]
 
: [[t(12;14)(p13;q11) TRA or TRD/CCND2]]
 
: [[t(14;14)(q11;q32.1) TRA-TRD/TCL1A]]
 
: [[t(14;21)(q11;q22) TRA/OLIG2]]
 
: [[t(1;12)(q21;p13) ETV6/ARNT]]
 
: [[t(1;14)(p32;q11) TRA/TAL1]]
 
: [[t(1;19)(q23;p13) TCF3/PBX1]]
 
: [[t(1;2)(p36;p21) PRDM16 and LINC00982/?]]
 
: [[t(1;3)(p32;p21) TCTA/TAL1]]
 
: [[t(1;5)(p32;q31) ?/TAL1]]
 
: [[t(1;7)(p32;q34) TRB/TAL1]]
 
: [[t(1;7)(p34;q34) TRB/LCK]]
 
: [[t(2;14)(p13-16;q32) IGH/BCL11A]]
 
: [[t(2;21)(q11;q22)]]
 
: [[t(3;11)(q12;p15) NUP98/LNP1]]
 
: [[t(3;11)(q29;p15) NUP98/IQCG]]
 
: [[t(4;11)(q21;p15) NUP98/RAP1GDS1]]
 
: [[t(4;11)(q21;q23) KMT2A/AFF1]]
 
: [[t(4;21)(q31;q22) RUNX1/?]]
 
: [[t(5;12)(q13;p13) ?/ETV6]]
 
: [[t(5;14)(q35;q11) TRD/NKX2-5]]
 
: [[t(5;14)(q35;q32) BCL11B/TLX3]]
 
: [[t(5;14)(q35;q32.2) BCL11B/TLX3 and NKX2-5]]
 
: [[t(5;17)(q13;q21)]]
 
: [[t(5;6)(q33-34;q23) CEP85L/PDGFRB]]
 
: [[t(5;7)(q35;q21) TLX3/CDK6]]
 
: [[t(6;11)(q27;q23) KMT2A/MLLT4]]
 
: [[t(6;7)(q23;q34) TRB/MYB and AHI1]]
 
: [[t(7;10)(q34;q24) TRD/TLX1]]
 
: [[t(7;11)(q35;p13) TBB/LMO2]]
 
: [[t(7;12)(q34;p13) TRB/CCND2]]
 
: [[t(7;14)(p15;q11) TRD/HOXA10]]
 
: [[t(7;14)(q35;q32.1) TRB/TCL1A]]
 
: [[t(7;19)(q34;p13) TRB/LYL1]]
 
: [[t(7;7)(p15;q34) TRB/HOXA10]]
 
: [[t(7;9)(q34;q32) TRB/TAL2]]
 
: [[t(7;9)(q34;q34) TRB-NOTCH1]]
 
: [[t(8;12)(q13;p13) ETV6/NCOA2]]
 
: [[t(8;14)(q24;q11) TRA/MYC]]
 
: [[t(8;21)(q24;q22) RUNX1/TRPS1]]
 
: [[t(8;9)(p22;p24) PCM1/JAK2]]
 
: [[t(9;12)(p24;p13) ETV6/JAK2]]
 
: [[t(9;12)(q34;p13) ETV6/ABL1]]
 
: [[t(9;14)(q34;q32) EML1/ABL1]]
 
: [[t(9;22)(q34;q11) BCR/ABL1 in ALL]]
 
: [[t(X;11)(q13;q23) KMT2A/FOXO4]]
 
: [[t(X;7)(q22;q34) IRS4/TRB]]
 
  
==Non Hodgkin Lymphomas (NHL)==
 
  
: [[Classification of B-cell non-Hodgkin's lymphomas (NHL)]]
+
==Deletions==
: [[+12 or trisomy 12]]
 
: [[+18 or trisomy 18 in lymphoproliferative disorders]]
 
: [[+20 or trisomy 20 (solely)]]
 
: [[+3 or trisomy 3 in non Hodgkin's lymphoma (NHL)]]
 
: [[+8 or trisomy 8]]
 
: [[12p rearrangements in CLL]]
 
: [[15q13-15 Rearrangements]]
 
: [[1q triplication in hematologic malignancies]]
 
: [[3q27 rearrangements (BCL6) in non Hodgkin lymphoma]]
 
: [[ALK -positive diffuse large B-cell lymphoma]]
 
: [[Anaplastic B-cell lymphoma]]
 
: [[Anaplastic large cell lymphoma (ALCL)]]
 
: [[Angioimmunoblastic T-cell lymphoma]]
 
: [[Burkitt's lymphoma (BL)]]
 
: [[Centroblastic lymphoma]]
 
: [[Classification of B-cell non-Hodgkin lymphomas (NHL)]]
 
: [[Classification of T-Cell disorders]]
 
: [[Cutaneous T-cell lymphomas]]
 
: [[Diffuse large cell lymphoma]]
 
: [[Follicular lymphoma (FL)]]
 
: [[Hepatosplenic T-cell lymphoma (HSTCL)]]
 
: [[Hodgkin lymphoma]]
 
: [[Immunoblastic lymphoma]]
 
: [[Intestinal T-cell lymphoma]]
 
: [[Lymphoepithelioid lymphoma]]
 
: [[Lymphoplasmacytic lymphoma]]
 
: [[Mantle cell lymphoma (incomplete)]]
 
: [[Marginal Zone B-cell lymphoma]]
 
: [[Mucosa-associated lymphoid tissue (MALT) lymphoma]]
 
: [[Mycosis fungoides/Sezary's syndrome]]
 
: [[NK cell neoplasias]]
 
: [[Nasal T cell lymphoma]]
 
: [[Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)]]
 
: [[Primary cutaneous CD30+ anaplastic large cell lymphoma]]
 
: [[Small lymphocytic lymphoma]]
 
: [[T-cell large granular lymphocyte leukaemia]]
 
: [[T-cell/histiocyte-rich large B cell lymphoma]]
 
: [[Waldenstrom's macroglobulinemia (WM)]]
 
: [[del (13q)]]
 
: [[del(11q) in non-Hodgkin's lymphoma (NHL)]]
 
: [[del(13q) in non-Hodgkin's lymphoma]]
 
: [[del(17p) in non-Hodgkin's lymphoma (NHL)]]
 
: [[del(3)(q27q27) ST6GAL1/BCL6]]
 
: [[del(6q) abnormalities in lymphoid malignancies]]
 
: [[del(7q) in non-Hodgkin's lymphoma (NHL)]]
 
: [[dic(9;12)(p13;p13) PAX5/ETV6]]
 
: [[ins(12;8)(p11;p12p22) FGFR1OP2/FGFR1]]
 
: [[inv(14)(q11q32.1) TRA-TRD/TCL1A]]
 
: [[inv(18)(p11q21)]]
 
: [[inv(2)(p23q35) ATIC/ALK]]
 
: [[inv(7)(p15q34) TRB/HOXA10]]
 
: [[t(10;11)(q22;q23) KMT2A/TET1]]
 
: [[t(10;14)(q24;q11) TRD/TLX1]]
 
: [[t(11;14)(q13;q32) IGH/CCND1]]
 
: [[t(11;18)(q21;q21) BIRC3/MALT1]]
 
: [[t(12;14)(p13;q32) IGH/CCND2]]
 
: [[t(12;22)(p13;q11) IGL/CCND2]]
 
: [[t(14;14)(q11;q32.1) TRA-TRD/TCL1A]]
 
: [[t(14;15)(q32;q11) IGH/NBEAP1]]
 
: [[t(14;18)(q32;q21) IGH/BCL2]]
 
: [[t(14;18)(q32;q21) IGH/MALT1]]
 
: [[t(14;19)(q32;q13) IGH/BCL3]]
 
: [[t(14;22)(q32;q11) IGH/IGL]]
 
: [[t(18;22)(q21;q11) IGL/BCL2]]
 
: [[t(19;22)(q13;q11) BCL3/IGL]]
 
: [[t(1;1)(p36;q21) in Non Hodgkin Lymphoma]]
 
: [[t(1;13)(q32;q14)]]
 
: [[t(1;14)(p22;q32) IGH/BCL10]]
 
: [[t(1;14)(q21;q32)]]
 
: [[t(1;14)(q21;q32) BCL9/IGH]]
 
: [[t(1;14)(q21;q32) FCGR2B/IGH]]
 
: [[t(1;14)(q21;q32) FCRL4/IGH]]
 
: [[t(1;14)(q21;q32) MUC1/IGH]]
 
: [[t(1;16)(q11;q11)]]
 
: [[t(1;19)(q23;p13) TCF3/PBX1]]
 
: [[t(1;2)(p22;p12) IGK/BCL10]]
 
: [[t(1;2)(q25;p23) TPM3/ALK]]
 
: [[t(1;22)(q21;q11)]]
 
: [[t(1;22)(q21;q11) IGL/BCL9]]
 
: [[t(1;3)(p36;p21)]]
 
: [[t(1;3)(q25;q27) GAS5/BCL6]]
 
: [[t(1;7)(q21;q22)]]
 
: [[t(1;8)(p22-p32;q22-q23)]]
 
: [[t(2;12)(p12;p13) IGK/CCND2]]
 
: [[t(2;12)(q31;p13) ETV6/?]]
 
: [[t(2;14)(p13-16;q32) IGH/BCL11A]]
 
: [[t(2;17)(p23;q23) CLTC/ALK]]
 
: [[t(2;17)(p23;q25) RNF213/ALK]]
 
: [[t(2;18)(p11;q21) IGK/BCL2]]
 
: [[t(2;18)(q11;q21) AFF3/BCL2]]
 
: [[t(2;19)(p12;q13) IGK/BCL3]]
 
: [[t(2;19)(p23;p13) TPM4/ALK]]
 
: [[t(2;22)(p23;q11) CLTCL1/ALK]]
 
: [[t(2;22)(p23;q11) MYH9/ALK]]
 
: [[t(2;3)(p12;q27) IGK/BCL6]]
 
: [[t(2;3)(p23;q21) TFG/ALK]]
 
: [[t(2;5)(p23;q35) NPM1/ALK]]
 
: [[t(2;5)(p23;q35) SQSTM1/ALK]]
 
: [[t(2;6)(p12;p25) IRF4/IGK]]
 
: [[t(2;8)(p12;q24) IGK/MYC]]
 
: [[t(2;8)(p15;q24) BCL11A/MYC]]
 
: [[t(2;9)(p23;q33) TRAF1/ALK]]
 
: [[t(3;11)(q27;q23) POU2AF1/BCL6]]
 
: [[t(3;12)(q27;p12) LRMP/BCL6]]
 
: [[t(3;12)(q27;p13) GAPDH/BCL6]]
 
: [[t(3;13)(q27;q14) LCP1/BCL6]]
 
: [[t(3;14)(p14;q32) IGH/FOXP1]]
 
: [[t(3;14)(q21;q32)]]
 
: [[t(3;14)(q27;q32) HSP90AA1/BCL6]]
 
: [[t(3;14)(q27;q32) IGH/BCL6]]
 
: [[t(3;16)(q27;p11) IL21R/BCL6]]
 
: [[t(3;16)(q27;p13) CIITA/BCL6]]
 
: [[t(3;19)(q27;q13) NAPA/BCL6]]
 
: [[t(3;22)(q27;q11) IGL/BCL6]]
 
: [[t(3;3)(q25;q27) MBNL1/BCL6]]
 
: [[t(3;3)(q27;q27) ST6GAL1/BCL6]]
 
: [[t(3;3)(q27;q28) EIF4A2/BCL6]]
 
: [[t(3;3)(q27;q29) TFRC/BCL6]]
 
: [[t(3;4)(q27;p13) RHOH/BCL6]]
 
: [[t(3;6)(q27;p21)]]
 
: [[t(3;6)(q27;p21) PIM1/BCL6]]
 
: [[t(3;6)(q27;p21) SRSF3/BCL6]]
 
: [[t(3;6)(q27;p22) HIST1H4I/BCL6]]
 
: [[t(3;6)(q27;q14) SNHG5/BCL6]]
 
: [[t(3;6)(q27;q15) ?/BCL6]]
 
: [[t(3;7)(q27;p12) IKZF1-BCL6]]
 
: [[t(3;7)(q27;q32) FRA7H/BCL6]]
 
: [[t(3;7)(q27;q32) MIR29A/BCL6]]
 
: [[t(3;8)(q27;q24) BCL6/MYC]]
 
: [[t(3;9)(q26;p23) ?/MECOM]]
 
: [[t(3;9)(q27;p13) GRHPR/BCL6]]
 
: [[t(3;9)(q27;p24) DMRT1/BCL6]]
 
: [[t(3;Var)(q27;Var) in non Hodgkin lymphoma]]
 
: [[t(4;12)(p16;p13) ETV6/FGFR3]]
 
: [[t(4;16)(q26;p13) IL2/TNFRSF17]]
 
: [[t(5;9)(q33;q22) ITK/SYK]]
 
: [[t(6;12)(p21;p13) CCND3/ETV6 in lymphoid malignancies]]
 
: [[t(6;14)(p25.3;q11.2) TRA/IRF4]]
 
: [[t(6;14)(p25;q32) IRF4/IGH]]
 
: [[t(6;20)(q15;q11.2) BACH2/BCL2L1]]
 
: [[t(6;22)(p25;q11) IRF4/IGL]]
 
: [[t(6;7)(p25.3;q32.3) DUSP22/FRA7H]]
 
: [[t(6;8)(q11;q11)]]
 
: [[t(6;8)(q27;p12) FGFR1OP/FGFR1]]
 
: [[t(7;10)(q34;q24) TRD/TLX1]]
 
: [[t(7;14)(q35;q32.1) TRB/TCL1A]]
 
: [[t(7;7)(p15;q34) TRB/HOXA10]]
 
: [[t(7;8)(p12;q24) /MYC]]
 
: [[t(8;12)(p12;p11) FGFR1OP2/FGFR1]]
 
: [[t(8;12)(q24;p12) LRMP/MYC]]
 
: [[t(8;13)(p11;q12) ZMYM2/FGFR1]]
 
: [[t(8;14)(q24;q11) TRA/MYC]]
 
: [[t(8;14)(q24;q32) IGH/MYC]]
 
: [[t(8;22)(q24;q11) IGL/MYC]]
 
: [[t(8;9)(p22;p24) PCM1/JAK2]]
 
: [[t(8;9)(q24;p13) ?/MYC]]
 
: [[t(8;9)(q24;q13)]]
 
: [[t(9;14)(p13;q32) PAX5/IGH]]
 
: [[t(X;14)(p11.4;q32.33) IGH/GPR34]]
 
: [[t(X;2)(q11;p23) MSN/ALK]]
 
  
==Chronic Lymphoproliferative Diseases (CLD)==
+
{| class="wikitable"
 +
|+DELETIONS
 +
|-
 +
|'''ANOMALY'''
 +
|'''ASSOCIATED DISORDERS with FISH test'''
 +
|'''GENES'''
 +
|-
 +
|[[del(1)(p32p36)]]
 +
|[[NHL]],[[ MM]]
 +
|-
 +
|[[del(1)(p32-34p36.1)]]
 +
|-
 +
|[[del(1)(p36.1)]]
 +
|[[Neuroblastoma]]
 +
|[[TP73(P73)]]
 +
|-
 +
|[[del(3)(p13p21)]]
  
: [[Classification of B-cell chronic lymphoproliferative disorders (CLD)]]
+
|-
: [[+12 or trisomy 12]]
+
|[[del(3)(q21)]]
: [[+15 or trisomy 15 (as sole autosomal abnormality)]]
+
|[[B-ALL]],[[ AML]],[[ NHL]]
: [[+16 or trisomy 16 (solely)]]
+
 
: [[+18 or trisomy 18 in lymphoproliferative disorders]]
+
|-
: [[+20 or trisomy 20 (solely)]]
+
|[[del(5)(q13q33) ]]
: [[+8 or trisomy 8]]
+
|[[AML]],[[ MDS]],[[ MPD]]
: [[-21 or monosomy 21 (solely)]]
+
|[[ PDGFRB]]
: [[12p rearrangements in CLL]]
+
|-
: [[1q rearrangements in multiple myeloma]]
+
|[[del(5)(q15q33) ]]
: [[1q triplication in hematologic malignancies]]
+
|[[AML]],[[ MDS]],[[ MPD]]
: [[Adult T-cell leukemia/lymphoma (ATLL)]]
+
|[[ PDGFRB ]]
: [[B-cell prolymphocytic leukemia (B-PLL)]]
+
|-
: [[Chronic lymphocytic leukaemia (CLL)]]
+
|[[del(5)(q22q35) ]]
: [[Classification of B-cell chronic lymphoproliferative disorders (CLD)]]
+
|[[AML]],[[ MDS]],[[ MPD]]
: [[Classification of T-Cell disorders]]
+
|[[ PDGFRB ]]
: [[Fibrogenesis imperfecta ossium]]
+
|-
: [[Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia Variant (HCL-V)]]
+
|[[del(5)(q31q35)]]
: [[Lymphomatoid papulosis (LyP) with 6p25.3 rearrangement DUSP22 and IRF4/]]
+
|[[AML]],[[ MDS]],[[ MPD]]
: [[Multiple myeloma]]
+
|[[ PDGFRB ]]
: [[Plasma cell leukemia (PCL)]]
+
|-
: [[Polyclonal B Lymphocytosis with Binucleated Lymphocytes (PPBL)]]
+
|[[del(6)(q13q21)]]
: [[Splenic lymphoma with villous lymphocytes (SLVL)]]
+
|[[WM/LPL]],[[ MM]],[[ NK lymphoma]],[[ DLBCL]]
: [[T-cell prolymphocytic leukemia (T-PLL)]]
+
|[[BLMP1-PRDM1]]
: [[del (13q)]]
+
|-
: [[del(13q) in chronic lymphoproliferative diseases]]
+
|[[del(6)(q13q23) A]]
: [[del(13q) in multiple myeloma]]
+
|[[CLL]],[[ atypical CLL]],[[ FL]],[[ MCL]],[[ T-NHL]],[[ childhood B-ALL]],[[ childhood T-ALL]],[[ adult ALL]],[[ MM]]
: [[del(6q) abnormalities in lymphoid malignancies]]
+
|-
: [[del(6q) in Multiple Myeloma]]
+
|[[del(6)(q15q21)]]
: [[inv(14)(q11q32.1) TRA-TRD/TCL1A]]
+
 
: [[inv(19)(p13q13) TCF3/TFPT]]
+
|-
: [[t(11;14)(p11;q32)]]
+
|[[del(6)(q21) A]]
: [[t(11;14)(q13;q32) IGH/CCND1]]
+
|[[CLL]],[[ atypical CLL]],[[ AML]],[[ childhood B-ALL]],[[ childhood T-ALL]],[[ adult ALL]],[[ MM]]
: [[t(11;14)(q13;q32) IGH/CCND1 in multiple myeloma]]
+
|-
: [[t(13;19)(q14;p13) TCF3/?]]
+
|[[del(7)(p15)]]
: [[t(14;14)(q11;q32.1) TRA-TRD/TCL1A]]
+
|-
: [[t(14;18)(q32;q21) IGH/BCL2]]
+
|[[del(7)(p13) ]]
: [[t(14;19)(q32;q13) IGH/BCL3]]
+
|[[AML]],[[ NHL]]
: [[t(14;22)(q32;q11) IGH/IGL]]
+
|-
: [[t(18;22)(q21;q11) IGL/BCL2]]
+
|[[del(7)(p13p15)]]
: [[t(19;19)(p13;q13) TCF3/TFPT]]
+
 
: [[t(19;22)(q13;q11) BCL3/IGL]]
+
|-
: [[t(1;14)(q21;q32) FCRL4/IGH]]
+
|[[del(7)(p11.2)]]
: [[t(1;3)(p36;q21) PSMD2/PRDM16]]
+
|[[B-ALL]],[[ AML]],[[ MDS]]
: [[t(1;6)(p35;p25) ?/IRF4]]
+
|-
: [[t(1;6)(p36;p21)]]
+
|[[del(7)(q11.2)]]
: [[t(2;14)(p13-16;q32) IGH/BCL11A]]
+
|[[B-ALL]],[[ AML]],[[ MDS]]
: [[t(2;18)(p11;q21) IGK/BCL2]]
+
 
: [[t(2;19)(p12;q13) IGK/BCL3]]
+
|-
: [[t(2;6)(p12;p25) IRF4/IGK]]
+
|[[del(7)(q22q34) A]]
: [[t(2;7)(p11;q21) IGK/CDK6]]
+
|[[AML]],[[ MDS]],[[ NHL]]
: [[t(4;14)(p16;q32) IGH/FGFR3 and WHSC1]]
+
 
: [[t(6;12)(p21;p13) CCND3/ETV6 in lymphoid malignancies]]
+
|-
: [[t(6;14)(p21;q32) IGH/CCND3]]
+
|[[del(7)(q32q34) A]]
: [[t(6;14)(p25;q32) IRF4/IGH]]
+
|[[AML]],[[ MDS]],[[ NHL]]
: [[t(6;14)(q25-27;q32) BCL11B/?]]
+
 
: [[t(6;22)(p21;q11)]]
+
|-
: [[t(6;22)(p25;q11) IRF4/IGL]]
+
|[[del(7)(q32) A]]
: [[t(7;14)(q21;q32) ERVW-1/IgH]]
+
|[[AML]],[[ MDS]],[[ NHL]]
: [[t(7;14)(q21;q32) IGH/CDK6]]
+
|-
: [[t(7;14)(q35;q32.1) TRB/TCL1A]]
+
|[[del(8)(p21)]]
: [[t(7;22)(q21;q11) IGL/CDK6]]
+
|-
: [[t(8;12)(q24;q22) BTG1/MYC]]
+
|[[del(8)(q22)]]
: [[t(8;17)(q24;q22) ???BCL3/MYC]]
+
|-
: [[t(9;14)(p13;q32) PAX5/IGH]]
+
|[[del(9)(p13)]]
: [[t(X;11)(q21;q23) BRWD3/ARHGAP20]]
+
|[[B-ALL]],[[ NHL]],[[ pediatric B-ALL ]]
 +
 
 +
|-
 +
|[[del(9)(p13p22)]]
 +
|[[B-ALL]]
 +
|-
 +
|[[del(9)(p21)]]
 +
|[[B-ALL]],[[ AML]],[[ NHL]]
 +
 
 +
|-
 +
|[[del(9)(p22) ]]
 +
|[[B-ALL]]
 +
 
 +
|-
 +
|[[del(9)(q13) ]]
 +
|[[AML M1]],[[ M2]],[[ M4]],[[ M6]]
 +
 
 +
|-
 +
|[[del(9)(q13q22)]]
 +
|[[AML]],[[ MDS]]
 +
 
 +
|-
 +
|[[del(10)(q24)]]
 +
 
 +
|-
 +
|[[del(11)(p11.2) ]]
 +
|[[NHL]]
 +
 
 +
|-
 +
|[[del(11)(p12p13) ]]
 +
|[[B-ALL]]
 +
|[[LMO2]]
 +
|-
 +
|[[del(11)(q13)]]  
 +
|Missing
 +
|-
 +
|[[del(11)(q13q21)]]  
 +
|Missing
 +
|-
 +
|[[del(11)(q13q23)]]
 +
|[[AML]],[[ CLL]],[[ MDS]],[[ NHL]]
 +
|[[ATM]]
 +
|-
 +
|[[del(11)(q21q23)]]
 +
|[[AML]]
 +
|[[MLL]]
 +
|-
 +
|[[del(11)(q23) ]]
 +
|[[AML]],[[ B-ALL]],[[ CLL]],[[ MDS]],[[ NHL]]
 +
|[[MLL]]
 +
|-
 +
|[[add(12)(p)/ del(12)(p11.2p13)]]
 +
|[[AML]],[[ MDS]],[[ B-ALL]]
 +
|[[ETV6(TEL)]]
 +
|-
 +
|[[del(13)(q12q14) A B]]
 +
|[[AML]],[[ AMM]],[[ MDS]],[[ NHL]]
 +
 
 +
|-
 +
|[[del(13)(q12q22) A B]]
 +
|[[AML]],[[ PMF]],[[ CLL]],[[ MM]],[[ MDS]],[[ NHL]]
 +
|-
 +
|[[del(14)(q24) ]]
 +
|[[NHL]]
 +
|-
 +
|[[del(16)(q22) ]]
 +
|[[AML]],[[ AML-M4Eo]],[[ NHL]]
 +
 
 +
|-
 +
|[[del(17)(p11.2) A]]
 +
|[[B-ALL]],[[ AML]],[[ CLL]],[[  MDS]],[[ NHL]]
 +
|[[TP53(P53)]]
 +
|-
 +
|[[del(18)(q21)]]
 +
|[[AML]],[[ NHL]]
 +
 
 +
|-
 +
|[["del(20)(q11.2q13.1)
 +
del(20)(q11.2q13.3)"]]
 +
|[[AML]],[[ MDS]],[[ MPD]]
 +
|-
 +
|[[ider(20)(p11.1)del(20)(q11.2q13.3)]]
 +
|[[AML]],[[ MDS]],[[ MPD]]
 +
|[["
 +
|-
 +
|[[del(X)(q24)]]
 +
|[[NHL]]
 +
 
 +
|}
 +
 
 +
==Numerical Abnormalities==
 +
 
 +
{| class="wikitable"
 +
|+NUMERICAL
 +
|-
 +
|'''ANOMALY'''
 +
|'''ASSOCIATED DISORDERS with FISH test'''
 +
|'''GENES'''
 +
|-
 +
|[[+3]]
 +
|[[SLVL]],[[ T-cell lymphoma]],[[ MZL]],[[ MCL]],[[ MALT]]
 +
|-
 +
|[[+4]]
 +
|[[AML M1-M2 and M4]],[[ and treatment related AML]]
 +
|-
 +
|[[+8]]
 +
|[[B-ALL]],[[ AML]],[[ MPD]],[[ MDS]],[[ PV]]
 +
|-
 +
|[[+9]]
 +
|[[AML]],[[ MDS]],[[ MPD]],[[ PV]],[[ B-ALL]],[[ T-ALL]]
 +
|-
 +
|[[+10]]
 +
|[[AML]],[[ B-ALL]],[[ MDS]]
 +
|-
 +
|[[+11]]
 +
|[[AML M1]],[[ M2]],[[ M4]],[[ MDS ]]
 +
|-
 +
|[[+12]]
 +
|[[AML]],[[ CLL]],[[ NHL]],[[ MALT]],[[ HCL]],[[ SLVL]],[[ WM/LPL]],[[ FL]],[[ MCL and DLBCL]]
 +
|-
 +
|[[+13/+13,+13]]
 +
|[[AML-M0]]
 +
|-
 +
|[[+14]]
 +
|[[MDS RA]],[[ RAEB±T mainly]],[[ AML M1]],[[ M2]],[[ M4]],[[ atypical MPD]]
 +
|-
 +
|[[+15]]
 +
|Age related when sole anomaly or with -Y
 +
|-
 +
|[[+19]]
 +
|[[AML]],[[ MDS]]
 +
|-
 +
|[[+21]]
 +
|[[AML]],[[ B-ALL]],[[ MDS]],[[ MPD]]
 +
|-
 +
|[[+22]]
 +
|[[AML-M4eo]]
 +
|-
 +
|[[-7  A B]]
 +
|[[MDS]],[[ RAEB/RAEB±T]],[[ CMML]],[[ J-CML]],[[ AML most often M4 or M6.]]
 +
|-
 +
|[[-Y ]]
 +
|age related when sole anomaly
  
==Other==
+
|}
  
: [[Castleman's disease]]
+
==Primarily Pediatric==
 +
 
 +
{| class="wikitable"
 +
|+PEDIATRIC
 +
|-
 +
|'''ANOMALY'''
 +
|'''ASSOCIATED DISORDERS with FISH test'''
 +
|'''GENES'''
 +
|-
 +
|[[t(1;19)(q23;p13.3)]]
 +
|[[B-ALL]]
 +
|[[PBX1-TCF3(E2A)]]
 +
|-
 +
|[[der(19)t(1;19)(q23;p13.3)]]
 +
|[[B-ALL]]
 +
|[[PBX1-TCF3(E2A)]]
 +
|-
 +
|[[t(8;14)(q11;q32)]]
 +
|[[B-ALL]]
 +
|[[CEBPD-IGH]]
 +
|-
 +
|[[i(9)(q10)/idic(9)(q10)]]
 +
|[[B-ALL]]
 +
|-
 +
|[[dic(9;12)(p11;p11.2)]]
 +
|[[B-ALL]]
 +
|-
 +
|[[dic(9;20)(p11;q11)]]
 +
|[[B-ALL]]
 +
|[[PAX5]]
 +
|-
 +
|[[t(17;19)(q22;p13)]]
 +
|[[B-ALL]]
 +
|[[TCF3(E2A)-HLF]]
 +
|-
 +
|[[t(1;22)(p13;q13)]]
 +
|[[AML M7]]
 +
|[[RBM15-MKL1]]
 +
|-
 +
|[[t(10;11)(p13;q23) ]]
 +
|[[Primarily AML ]],[[ uncommonly B-ALL]]
 +
|[[MLLT10(AF10)/MLL]]
 +
|-
 +
|[[t(16;21)(p11.2;q22)]]
 +
|[[AML]]
 +
|[[FUS-ERG]]
 +
|-
 +
|[[t(16;21)(q24;q22)]]
 +
|[[AML]]
 +
|[[CBFA2T3-RUNX1-(AML1)]]
 +
|-
 +
|[[t(10;11)(p13;q14)]]
 +
|[[T-ALL]]
 +
|[[MLLT10(AF10)/PICALM ]]
 +
|-
 +
|[[t(11;14)(p15;q11.2)]]
 +
|[[T-ALL]]
 +
|[[LMO1-TRA]]
 +
|-
 +
|[[t(11;14)(p13;q11-q11.2) ]]
 +
|[[T-ALL]]
 +
|[[LMO2(Rhom2)-TRA]]
 +
 
 +
|}

Revision as of 11:11, 3 September 2015

Translocations

Translocations
ANOMALY ASSOCIATED DISORDERS with FISH test GENES
der(1)t(1;1)(p36;q21) NHL
t(1;3)(p36;q21) MDS,AML PRDM16(MEL1)-RPN1
t(1;3;5)(p36;p21;q33) CEL WDR48-PDGFRB
t(1;5)(q21;q33) MPD TPM3-PDGFRB 
t(1;5)(q22;q33) MPD with eosinophilia,CEL,B-ALL PDE4DIP-PDGFRB
der(1;7)(q10;p10) MDS,AML,MPD
t(1;8)(p13;q24.1) Missing MYC(C-MYC)
t(1;14)(q21;q32) A B C D B-ALL,NHL BCL9-IGH,FCGR2B-IGH,FCRL4-IGH,MUC1/IGH
t(1;19)(q23;p13.3) B-ALL PBX1-TCF3(E2A)
der(1;22)(q10;p10)
t(2;5)(p23;q35) ALCL,NHL ALK-NPM1
t(2;8)(p12;q24.1) BL,B-ALL,NHL MYC(C-MYC)
t(2;11)(p21;q23) MDS,AML,B-ALL MLL
t(2;14)(p15;q32) CLL,NHL,B-ALL,T-ALL,AML
t(3;3)(q21;q26.2) MDS,AML RPN1-MECOM(EVI1)
t(3;5)(p21-25;q32-35) MPD GOLGA4-PDGFRB 
t(3;21)(q26.2;q22) A t-AML,t-MDS RPL22(EAP)-RUNX1(AML1)
t(4;11)(q21;q23) B-ALL,T-ALL AFF1(AF4)-MLL
t(4;14)(p16.3;q32) MM FGFR3-IGH
t(4;22)(q12;q11) atypical MPD PDGFRA -BCR
t(4;5;5)(q23;q31;q33) chronic basophilic leukemia PRKG2-PDGFRB
t(5;7)(q33;q11.2) CMML HIP1-PDGFRB
t(5;10)(q33;q21) atypical MPD CCD6-PDGFRB
t(5;12)(q31;p13) CEL,MPD ETV6(TEL)-ACSL6
t(5;12)(q33;q24) MPD with eosinophilia   GIT2-PDGFRB
t(5;12)(q33;p13) CMML,MDS,MPD ETV6(TEL)-PDGFRB
t(5;14)(q33;q24) MPD,atypical MPD NIN-PDGFRB
t(5;14)(q33;q32) CCDC88C(KIAA1509)-PDGFRB
t(5;15)(q33;q22) CMML atypical MPD TP53BP1-PDGFRB
t(5;14)(q35;q32) T-cell lymphoma TLX3(HOX11L2)-BCL11B
t(5;16)(q33;q22) AML CBFB
der(5;17)(p10;q10) MDS,AML NPM1(NPM)-RARA
t(5;17)(q33;p11.2) JMML SPECC1-PDGFRB
t(5;17)(q33;p13) CMML,atypical MPD RABEP1-PDGFRB 
der(6)t(1;6)(q21;p21.3) PMF
t(6;9)(p23;q34) MDS,AML DEK-NUP214 (CAN)
t(6;11)(q27;q23) AML,t-AML,T-ALL MLLT4(AF6)-MLL
t(7;11)(p15;p15) AML NUP98-HOXA9
t(8;14)(q24.1;q32) BL,B-ALL,NHL MYC(C-MYC)- IGH
t(8;16)(p11.2;p13.3) A AML M4,M5a,M5b,t-MDS KAT6A(MYST3)-CREBBP(CBP)
t(8;21)(q22;q22) A AML M2 mostly,rarely M1,M4 RUNX1(AML)-RUNX1T1(ETO)
t(8;22)(q24.1;q11.2) BL,B-ALL,NHL,MM MYC(C-MYC)-IGL(IGL)
add(9)(p24) JAK2
t(9;11)(p22;q23) AML mostly M5,M4,B-ALL MLLT3(AF9)-MLL
t(9;14)(p13;q32) MM,CLL,DLBCL,FL,MCL splenic MZL PAX5-IGH
t(9;22)(q34;q11.2) A B CML,B-ALL,T-ALL ABL1(ABL)-BCR
t(11;14)(q13;q32) A MCL,MM CCND1(BCL1)- IGH
t(11;14)(q23;q32) t-AML MLL-KIAA0284
t(11;16)(q23;p13.3) t-MDS,t-AML MLL-CREBBP(CBP)
t(11;17)(q23;q21) APL ZBTB16(PLZF)-RARA
t(11;18)(q21;q21) MALT BIRC3(API2)-MALT1
t(11;19)(q23;p13.1) AML MLL-ELL
t(11;19)(q23;p13.3) B-ALL,AML,T-ALL MLL-MLLT1(ENL)
t(14;16)(q32;q23) MM IGH-MAF
t(14;18)(q32;q21) BL,DLBCL,FL,CLL IGH-BCL2
t(14;19)(q32;q13.3) CLL,DLBCL,MCL,MZL,SLVL
t(14;22)(q32;q11.2) B-ALL,CLL,HCL,AML,NHL,DLBCL IGH-IGL
t(15;17)(q24;q21) APL PML-RARA
t(16;16)(p13.1;q22) AML M4Eo MYH11-CBFB
der(19)t(1;19)(q23;p13.3) B-ALL,L3-like ALL,T-ALL,NHL,AML PBX1-TCF3(E2A)
der(Y)t(Y;1)(q12;q12) MDS


Inversions

INVERSIONS
ANOMALY ASSOCIATED DISORDERS with FISH test GENES
inv(3)(q21q26.2) MDS,AML RPN1-MECOM(EVI1)
inv(11)(q21q23) MDS,AML M2,T-ALL MAML2-MLL
inv(14)(q11.2q32) PLL TRA-TCL1A(TCL1)
inv(16)(p13.1q22) AML M4Eo MYH11,CBFB

Duplications

DUPLICATIONS
ANOMALY ASSOCIATED DISORDERS with FISH test GENES
dup(1)(q11q44)
dup(1)(q21q32) B-ALL,NHL
dup(1)(q21q42)
dup(1)(q23q32)
dup(1)(q23q42) NHL
dup(11)(q13q25) NHL MLL
dup(12)(q13q22)


Isochromsomes

ISOCHROMOSOMES
ANOMALY ASSOCIATED DISORDERS with FISH test GENES
i(1)(q10) NHL
i(3)(q10) NHL
i(7)(q10) T-cell lymphoma
i(8)(q10) T-PLL,AML,B-ALL
i(11)(q10) AML M2,M4,MDS
i(17)(q10) MDS,MPD,AML,CML,B-ALL,CLL,Hodgkin and NHL
i(21)(q10) B-ALL,MDS,NHL,AML,CMML
idic(X)(q13) AML M1,M2,M4,MDS,RARS XIST

Cryptic

CRYPTIC
ANOMALY ASSOCIATED DISORDERS with FISH test GENES
t(12;21)(p13;q22) B-ALL ETV6 (TEL)-RUNX1(AML1)
t(X;14) B-ALL CRLF2-IGH
t(Y;14) B-ALL CRLF2-IGH
t(5;14)(q35;q32) T-ALL TLX3-BCL11B
del(1)(p32p32) B-ALL TAL1-STIL


Deletions

DELETIONS
ANOMALY ASSOCIATED DISORDERS with FISH test GENES
del(1)(p32p36) NHL,MM
del(1)(p32-34p36.1)
del(1)(p36.1) Neuroblastoma TP73(P73)
del(3)(p13p21)
del(3)(q21) B-ALL,AML,NHL
del(5)(q13q33) AML,MDS,MPD  PDGFRB
del(5)(q15q33) AML,MDS,MPD  PDGFRB 
del(5)(q22q35) AML,MDS,MPD  PDGFRB 
del(5)(q31q35) AML,MDS,MPD  PDGFRB 
del(6)(q13q21) WM/LPL,MM,NK lymphoma,DLBCL BLMP1-PRDM1
del(6)(q13q23) A CLL,atypical CLL,FL,MCL,T-NHL,childhood B-ALL,childhood T-ALL,adult ALL,MM
del(6)(q15q21)
del(6)(q21) A CLL,atypical CLL,AML,childhood B-ALL,childhood T-ALL,adult ALL,MM
del(7)(p15)
del(7)(p13) AML,NHL
del(7)(p13p15)
del(7)(p11.2) B-ALL,AML,MDS
del(7)(q11.2) B-ALL,AML,MDS
del(7)(q22q34) A AML,MDS,NHL
del(7)(q32q34) A AML,MDS,NHL
del(7)(q32) A AML,MDS,NHL
del(8)(p21)
del(8)(q22)
del(9)(p13) B-ALL,NHL,pediatric B-ALL
del(9)(p13p22) B-ALL
del(9)(p21) B-ALL,AML,NHL
del(9)(p22) B-ALL
del(9)(q13) AML M1,M2,M4,M6
del(9)(q13q22) AML,MDS
del(10)(q24)
del(11)(p11.2) NHL
del(11)(p12p13) B-ALL LMO2
del(11)(q13) Missing
del(11)(q13q21) Missing
del(11)(q13q23) AML,CLL,MDS,NHL ATM
del(11)(q21q23) AML MLL
del(11)(q23) AML,B-ALL,CLL,MDS,NHL MLL
add(12)(p)/ del(12)(p11.2p13) AML,MDS,B-ALL ETV6(TEL)
del(13)(q12q14) A B AML,AMM,MDS,NHL
del(13)(q12q22) A B AML,PMF,CLL,MM,MDS,NHL
del(14)(q24) NHL
del(16)(q22) AML,AML-M4Eo,NHL
del(17)(p11.2) A B-ALL,AML,CLL,MDS,NHL TP53(P53)
del(18)(q21) AML,NHL
[["del(20)(q11.2q13.1)

del(20)(q11.2q13.3)"]]

AML,MDS,MPD
ider(20)(p11.1)del(20)(q11.2q13.3) AML,MDS,MPD [["
del(X)(q24) NHL

Numerical Abnormalities

NUMERICAL
ANOMALY ASSOCIATED DISORDERS with FISH test GENES
+3 SLVL,T-cell lymphoma,MZL,MCL,MALT
+4 AML M1-M2 and M4,and treatment related AML
+8 B-ALL,AML,MPD,MDS,PV
+9 AML,MDS,MPD,PV,B-ALL,T-ALL
+10 AML,B-ALL,MDS
+11 AML M1,M2,M4,MDS
+12 AML,CLL,NHL,MALT,HCL,SLVL,WM/LPL,FL,MCL and DLBCL
+13/+13,+13 AML-M0
+14 MDS RA,RAEB±T mainly,AML M1,M2,M4,atypical MPD
+15 Age related when sole anomaly or with -Y
+19 AML,MDS
+21 AML,B-ALL,MDS,MPD
+22 AML-M4eo
-7 A B MDS,RAEB/RAEB±T,CMML,J-CML,AML most often M4 or M6.
-Y age related when sole anomaly

Primarily Pediatric

PEDIATRIC
ANOMALY ASSOCIATED DISORDERS with FISH test GENES
t(1;19)(q23;p13.3) B-ALL PBX1-TCF3(E2A)
der(19)t(1;19)(q23;p13.3) B-ALL PBX1-TCF3(E2A)
t(8;14)(q11;q32) B-ALL CEBPD-IGH
i(9)(q10)/idic(9)(q10) B-ALL
dic(9;12)(p11;p11.2) B-ALL
dic(9;20)(p11;q11) B-ALL PAX5
t(17;19)(q22;p13) B-ALL TCF3(E2A)-HLF
t(1;22)(p13;q13) AML M7 RBM15-MKL1
t(10;11)(p13;q23) Primarily AML ,uncommonly B-ALL MLLT10(AF10)/MLL
t(16;21)(p11.2;q22) AML FUS-ERG
t(16;21)(q24;q22) AML CBFA2T3-RUNX1-(AML1)
t(10;11)(p13;q14) T-ALL MLLT10(AF10)/PICALM 
t(11;14)(p15;q11.2) T-ALL LMO1-TRA
t(11;14)(p13;q11-q11.2) T-ALL LMO2(Rhom2)-TRA